Trial Profile
A safety and efficacy trial of albumin-bound paclitaxel as second line or greater chemotherapy lines in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2015 New trial record